Shabbir, A., Yumn, L. and Khan, E. (2024) “Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy”, Global Cardiology, 2(3). doi: 10.4081/cardio.2024.48.